Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGENOMICS INCNEO · Entity 2096 | Chief Financial Officer | April 28, 2022 | May 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGENOMICS INC
Report date April 28, 2022 · Filed May 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,548 |
Reported balance
After 2022-04-28 transaction · row 1
1 source rowRow 1 · 2022-04-28 · Exercise / conversion · Acquired 5,727 · Balance 191,548 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.52 · Expires 2022-04-28 | Direct | 0 |
Reported balance
After 2022-04-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-28 · Exercise / conversion · Disposed 5,727 · Balance 0 F1: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.03 · Expires 2023-02-26 | Direct | 45,370 |
Reported balance
Holding disclosure · report date 2022-04-28 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 45,370 F2: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.60 · Expires 2024-03-01 | Direct | 41,167 |
Reported balance
Holding disclosure · report date 2022-04-28 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 41,167 F3: On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.33 · Expires 2027-03-02 | Direct | 37,514 |
Reported balance
Holding disclosure · report date 2022-04-28 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 37,514 F4: On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.17 · Expires 2028-03-02 | Direct | 24,619 |
Reported balance
Holding disclosure · report date 2022-04-28 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 24,619 F5: On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.41 · Expires 2029-03-01 | Direct | 99,772 |
Reported balance
Holding disclosure · report date 2022-04-28 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 99,772 F6: On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F2: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F3: On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4: On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F5: On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6: On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2022 Filed May 2, 2022 21:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,727 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-22-000071 · wf-form4_165152792439687.xml · derivative · entry 2 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,727 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| April 28, 2022 Filed May 2, 2022 21:46 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 5,727 | $7.52 | $43,067.04 |
DisclosureSEC source: 0001077183-22-000071 · wf-form4_165152792439687.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 23:08 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 82,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000056 · wf-form4_164911365676278.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,821 F1 · shares: On April 1, 2022, Mr. Bonello was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 23:02 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-22-000049 · wf-form4_164686693130490.xml · derivative · entry 3 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,727 Underlying: Common Stock · 5,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 23:02 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 5,000 | $7.52 | $37,600.00 |
DisclosureSEC source: 0001077183-22-000049 · wf-form4_164686693130490.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 23:02 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 3,209 | $18.29 | $58,692.61 |
DisclosureSEC source: 0001077183-22-000049 · wf-form4_164686693130490.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,516 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,725 F3 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 99,772 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · derivative · entry 9 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,772 Underlying: Common Stock · 99,772 shares Expires 2029-03-01 F9 · derivative.exercise_date: On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 397 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,345 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 40,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,742 F1 · shares: On March 1, 2022, Mr. Bonello was granted 40,869 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:04 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000275 · wf-form4_164090542876784.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,873 F1 · kind: On December 30, 2021, Mr. Bonello was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:09 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-21-000254 · wf-form4_163848655622024.xml · derivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,727 Underlying: Common Stock · 25,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:09 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 25,000 | $7.52 | $188,000.00 |
DisclosureSEC source: 0001077183-21-000254 · wf-form4_163848655622024.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:16 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-21-000251 · wf-form4_163822054448872.xml · derivative · entry 4 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,370 Underlying: Common Stock · 25,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:16 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 25,000 | $37.13 | $928,250.00 |
DisclosureSEC source: 0001077183-21-000251 · wf-form4_163822054448872.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:16 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 25,000 | $8.03 | $200,750.00 |
DisclosureSEC source: 0001077183-21-000251 · wf-form4_163822054448872.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 24,619 | $53.17 Strike: $53.17 | $1,308,992.23 |
DisclosureSEC source: 0001077183-21-000085 · wf-form4_161482070863668.xml · derivative · entry 8 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,619 Underlying: Common Stock · 24,619 shares Expires 2028-03-02 F7 · derivative.exercise_date: On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 4,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000085 · wf-form4_161482070863668.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 432 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000085 · wf-form4_161482070863668.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,128 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000085 · wf-form4_161482070863668.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,560 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 23:03 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000217 · wf-form4_160712294905089.xml · derivative · entry 3 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,370 Underlying: Common Stock · 8,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 23:03 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 8,000 | $46.80 | $374,400.00 |
DisclosureSEC source: 0001077183-20-000217 · wf-form4_160712294905089.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,060 Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 23:03 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 8,000 | $8.03 | $64,240.00 |
DisclosureSEC source: 0001077183-20-000217 · wf-form4_160712294905089.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,964 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · derivative · entry 5 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,370 Underlying: Common Stock · 1,964 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,036 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · derivative · entry 4 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,727 Underlying: Common Stock · 20,036 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 22,000 | $38.61 | $849,420.00 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,060 Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 1,964 | $8.03 | $15,770.92 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 20,036 | $7.52 | $150,670.72 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 01:26 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock · Derivative | 37,514 | $28.33 Strike: $28.33 | $1,062,771.62 |
DisclosureSEC source: 0001077183-20-000043 · wf-form4_158328516474870.xml · derivative · entry 6 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,514 Underlying: Common Stock · 37,514 shares Expires 2027-03-02 F5 · derivative.exercise_date: On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 01:26 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 5,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000043 · wf-form4_158328516474870.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,060 Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:26 UTC | NEOGENOMICS INC NEO · Entity 2096 | Tax withholdingCommon Stock | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000043 · wf-form4_158328516474870.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,236 F1 · shares: Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:15 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000161 · wf-form4_156719970186232.xml · derivative · entry 3 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,763 Underlying: Common Stock · 72,763 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:15 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 17,000 | $24.83 | $422,110.00 |
DisclosureSEC source: 0001077183-19-000161 · wf-form4_156719970186232.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:15 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 17,000 | $7.52 | $127,840.00 |
DisclosureSEC source: 0001077183-19-000161 · wf-form4_156719970186232.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:02 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,200 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000068 · wf-form4_155734933349567.xml · derivative · entry 3 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,763 Underlying: Common Stock · 79,963 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:02 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 7,200 | $23.53 | $169,416.00 |
DisclosureSEC source: 0001077183-19-000068 · wf-form4_155734933349567.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Read SEC document |
| May 06, 2019 Filed May 8, 2019 21:02 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 7,200 | $7.52 | $54,144.00 |
DisclosureSEC source: 0001077183-19-000068 · wf-form4_155734933349567.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 41,167 | $19.60 Strike: $19.60 | $806,873.20 |
DisclosureSEC source: 0001077183-19-000027 · wf-form4_155182281921308.xml · derivative · entry 2 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,167 Underlying: Common Stock · 41,167 shares Expires 2024-03-01 F1 · derivative.expiration_date: On March 1, 2019, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 6,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000027 · wf-form4_155182281921308.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,037 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · derivative · entry 5 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,963 Underlying: Common Stock · 20,037 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 40,166 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · derivative · entry 4 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,334 Underlying: Common Stock · 40,166 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 60,203 | $18.90 | $1,137,836.70 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 20,037 | $7.52 | $150,678.24 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:59 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 40,166 | $8.03 | $322,532.98 |
DisclosureSEC source: 0001077183-19-000014 · wf-form4_155139117368318.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.